Recombinant CD19 (Tafasitamab Biosimilar) antibody (PE)

Catalog No. ABIN7828993

This Humanized Monoclonal antibody specifically detects CD19 (Tafasitamab Biosimilar) in FACS. It exhibits reactivity toward Human.

Quick Overview for Recombinant CD19 (Tafasitamab Biosimilar) antibody (PE) (ABIN7828993)

Target: CD19 (Tafasitamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD19 (Tafasitamab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-CD19 (Tafasitamab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-CD19(tafasitamab biosimilar) mAb

Isotype: IgG1, IgG2, kappa

Application Details

Application Notes: Flow Cyt 1 μL:test

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid,PBS with,0.18 % BSA,0.1 %Proclin300

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for CD19 (Tafasitamab Biosimilar)

Target: CD19 (Tafasitamab Biosimilar)

Alternative Name: Tafasitamab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD19,B4,CVID3,MGC12802
Synonyms Antibody:ICP-B04,ICP B04,MOR 208,MOR208,MOR-208,XENP-5574,XENP5574,XENP 5574,XmAb-5574,XmAb5574,XmAb 5574

UniProt: P15391